nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Dactinomycin—sarcoma	0.107	0.126	CbGbCtD
Zafirlukast—ABCG2—Mitoxantrone—sarcoma	0.0958	0.112	CbGbCtD
Zafirlukast—CYP2E1—Dacarbazine—sarcoma	0.088	0.103	CbGbCtD
Zafirlukast—CYP2E1—Mitoxantrone—sarcoma	0.0683	0.0801	CbGbCtD
Zafirlukast—ABCG2—Vincristine—sarcoma	0.0659	0.0773	CbGbCtD
Zafirlukast—ABCG2—Etoposide—sarcoma	0.0604	0.0709	CbGbCtD
Zafirlukast—PTGS1—Etoposide—sarcoma	0.0557	0.0654	CbGbCtD
Zafirlukast—CYP1A2—Dacarbazine—sarcoma	0.0509	0.0597	CbGbCtD
Zafirlukast—CYP3A4—Thiotepa—sarcoma	0.0481	0.0565	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—sarcoma	0.0431	0.0505	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—sarcoma	0.0412	0.0483	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—sarcoma	0.0322	0.0377	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—sarcoma	0.0249	0.0292	CbGbCtD
Zafirlukast—CYP3A4—Mitoxantrone—sarcoma	0.0207	0.0243	CbGbCtD
Zafirlukast—CYP3A4—Vincristine—sarcoma	0.0142	0.0167	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—sarcoma	0.014	0.0164	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—sarcoma	0.013	0.0153	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—sarcoma	0.0089	0.0104	CbGbCtD
Zafirlukast—CYSLTR2—hematopoietic system—sarcoma	0.00407	0.169	CbGeAlD
Zafirlukast—CYSLTR1—hematopoietic system—sarcoma	0.00153	0.0638	CbGeAlD
Zafirlukast—CYSLTR1—smooth muscle tissue—sarcoma	0.00135	0.0562	CbGeAlD
Zafirlukast—CYSLTR1—uterus—sarcoma	0.00116	0.0482	CbGeAlD
Zafirlukast—Hepatic failure—Vincristine—sarcoma	0.00112	0.00907	CcSEcCtD
Zafirlukast—Swelling—Mitoxantrone—sarcoma	0.00111	0.00899	CcSEcCtD
Zafirlukast—CYSLTR1—lymphoid tissue—sarcoma	0.00108	0.0449	CbGeAlD
Zafirlukast—Neuropathy—Etoposide—sarcoma	0.00106	0.00854	CcSEcCtD
Zafirlukast—Liver function test abnormal—Dactinomycin—sarcoma	0.00104	0.00842	CcSEcCtD
Zafirlukast—CYSLTR1—bone marrow—sarcoma	0.000982	0.0409	CbGeAlD
Zafirlukast—Swelling—Etoposide—sarcoma	0.000925	0.00748	CcSEcCtD
Zafirlukast—Neutropenia—Dactinomycin—sarcoma	0.000912	0.00737	CcSEcCtD
Zafirlukast—Haematemesis—Epirubicin—sarcoma	0.000907	0.00734	CcSEcCtD
Zafirlukast—Blister—Epirubicin—sarcoma	0.000875	0.00707	CcSEcCtD
Zafirlukast—Jaundice—Thiotepa—sarcoma	0.000854	0.0069	CcSEcCtD
Zafirlukast—Haemoptysis—Epirubicin—sarcoma	0.000852	0.00689	CcSEcCtD
Zafirlukast—Haematemesis—Doxorubicin—sarcoma	0.00084	0.00679	CcSEcCtD
Zafirlukast—Agranulocytosis—Thiotepa—sarcoma	0.000817	0.00661	CcSEcCtD
Zafirlukast—Neutropenia—Vincristine—sarcoma	0.000815	0.00658	CcSEcCtD
Zafirlukast—Agranulocytosis—Dactinomycin—sarcoma	0.000811	0.00656	CcSEcCtD
Zafirlukast—Blister—Doxorubicin—sarcoma	0.000809	0.00654	CcSEcCtD
Zafirlukast—Neutropenia—Mitoxantrone—sarcoma	0.000793	0.00641	CcSEcCtD
Zafirlukast—Haemoglobin—Thiotepa—sarcoma	0.00079	0.00639	CcSEcCtD
Zafirlukast—Haemoptysis—Doxorubicin—sarcoma	0.000788	0.00637	CcSEcCtD
Zafirlukast—Haemorrhage—Thiotepa—sarcoma	0.000786	0.00636	CcSEcCtD
Zafirlukast—Hepatitis—Dactinomycin—sarcoma	0.00078	0.00631	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Vincristine—sarcoma	0.000761	0.00615	CcSEcCtD
Zafirlukast—PTGS1—endothelium—sarcoma	0.000758	0.0316	CbGeAlD
Zafirlukast—Blood disorder—Epirubicin—sarcoma	0.000755	0.0061	CcSEcCtD
Zafirlukast—CYP2C8—mammary gland—sarcoma	0.000753	0.0314	CbGeAlD
Zafirlukast—Liver injury—Epirubicin—sarcoma	0.000749	0.00606	CcSEcCtD
Zafirlukast—Jaundice—Mitoxantrone—sarcoma	0.000737	0.00596	CcSEcCtD
Zafirlukast—Sinusitis—Mitoxantrone—sarcoma	0.00071	0.00574	CcSEcCtD
Zafirlukast—Agranulocytosis—Mitoxantrone—sarcoma	0.000706	0.00571	CcSEcCtD
Zafirlukast—Blood disorder—Doxorubicin—sarcoma	0.000698	0.00565	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Epirubicin—sarcoma	0.000698	0.00564	CcSEcCtD
Zafirlukast—Hypoaesthesia—Vincristine—sarcoma	0.000694	0.00561	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Epirubicin—sarcoma	0.000693	0.0056	CcSEcCtD
Zafirlukast—Liver injury—Doxorubicin—sarcoma	0.000693	0.0056	CcSEcCtD
Zafirlukast—Haemoglobin—Mitoxantrone—sarcoma	0.000682	0.00552	CcSEcCtD
Zafirlukast—Haemorrhage—Mitoxantrone—sarcoma	0.000679	0.00549	CcSEcCtD
Zafirlukast—Hepatitis—Mitoxantrone—sarcoma	0.000679	0.00549	CcSEcCtD
Zafirlukast—CYP2C9—mammary gland—sarcoma	0.000669	0.0279	CbGeAlD
Zafirlukast—Back pain—Thiotepa—sarcoma	0.000662	0.00535	CcSEcCtD
Zafirlukast—Neutropenia—Etoposide—sarcoma	0.00066	0.00533	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Doxorubicin—sarcoma	0.000646	0.00522	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.000642	0.00519	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dactinomycin—sarcoma	0.00063	0.0051	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Etoposide—sarcoma	0.000617	0.00499	CcSEcCtD
Zafirlukast—Jaundice—Etoposide—sarcoma	0.000613	0.00496	CcSEcCtD
Zafirlukast—Malaise—Dactinomycin—sarcoma	0.000613	0.00495	CcSEcCtD
Zafirlukast—Influenza like illness—Epirubicin—sarcoma	0.000612	0.00495	CcSEcCtD
Zafirlukast—CYSLTR1—lymph node—sarcoma	0.000608	0.0253	CbGeAlD
Zafirlukast—Neuropathy—Epirubicin—sarcoma	0.000592	0.00478	CcSEcCtD
Zafirlukast—Agranulocytosis—Etoposide—sarcoma	0.000587	0.00475	CcSEcCtD
Zafirlukast—Back pain—Vincristine—sarcoma	0.000587	0.00475	CcSEcCtD
Zafirlukast—Arthralgia—Thiotepa—sarcoma	0.000583	0.00471	CcSEcCtD
Zafirlukast—Myalgia—Thiotepa—sarcoma	0.000583	0.00471	CcSEcCtD
Zafirlukast—Myalgia—Dactinomycin—sarcoma	0.000578	0.00468	CcSEcCtD
Zafirlukast—Back pain—Mitoxantrone—sarcoma	0.000572	0.00462	CcSEcCtD
Zafirlukast—Discomfort—Dactinomycin—sarcoma	0.000571	0.00462	CcSEcCtD
Zafirlukast—Influenza like illness—Doxorubicin—sarcoma	0.000567	0.00458	CcSEcCtD
Zafirlukast—Hypoaesthesia—Etoposide—sarcoma	0.000562	0.00454	CcSEcCtD
Zafirlukast—Infection—Thiotepa—sarcoma	0.000555	0.00449	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—sarcoma	0.000554	0.00448	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—sarcoma	0.000551	0.00445	CcSEcCtD
Zafirlukast—Ill-defined disorder—Mitoxantrone—sarcoma	0.000548	0.00443	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—sarcoma	0.000548	0.00443	CcSEcCtD
Zafirlukast—Thrombocytopenia—Thiotepa—sarcoma	0.000547	0.00442	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dactinomycin—sarcoma	0.000543	0.00439	CcSEcCtD
Zafirlukast—Malaise—Mitoxantrone—sarcoma	0.000533	0.00431	CcSEcCtD
Zafirlukast—CYP2C19—hematopoietic system—sarcoma	0.000526	0.0219	CbGeAlD
Zafirlukast—Hepatic function abnormal—Epirubicin—sarcoma	0.000524	0.00423	CcSEcCtD
Zafirlukast—ABCG2—myometrium—sarcoma	0.00052	0.0216	CbGeAlD
Zafirlukast—Myalgia—Vincristine—sarcoma	0.000517	0.00418	CcSEcCtD
Zafirlukast—Hepatic failure—Epirubicin—sarcoma	0.000509	0.00412	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000509	0.00411	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000505	0.00408	CcSEcCtD
Zafirlukast—Myalgia—Mitoxantrone—sarcoma	0.000503	0.00407	CcSEcCtD
Zafirlukast—Arthralgia—Mitoxantrone—sarcoma	0.000503	0.00407	CcSEcCtD
Zafirlukast—Discomfort—Mitoxantrone—sarcoma	0.000497	0.00402	CcSEcCtD
Zafirlukast—Oedema—Vincristine—sarcoma	0.000495	0.004	CcSEcCtD
Zafirlukast—Infection—Vincristine—sarcoma	0.000492	0.00398	CcSEcCtD
Zafirlukast—Dyspepsia—Thiotepa—sarcoma	0.000492	0.00397	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vincristine—sarcoma	0.000485	0.00392	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—sarcoma	0.000485	0.00392	CcSEcCtD
Zafirlukast—Oedema—Mitoxantrone—sarcoma	0.000482	0.0039	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Thiotepa—sarcoma	0.000482	0.0039	CcSEcCtD
Zafirlukast—Fatigue—Thiotepa—sarcoma	0.000482	0.00389	CcSEcCtD
Zafirlukast—Infection—Mitoxantrone—sarcoma	0.000479	0.00387	CcSEcCtD
Zafirlukast—Dermatitis bullous—Epirubicin—sarcoma	0.000479	0.00387	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—sarcoma	0.000478	0.00386	CcSEcCtD
Zafirlukast—Pain—Thiotepa—sarcoma	0.000478	0.00386	CcSEcCtD
Zafirlukast—Back pain—Etoposide—sarcoma	0.000476	0.00384	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—sarcoma	0.000474	0.00383	CcSEcCtD
Zafirlukast—Thrombocytopenia—Mitoxantrone—sarcoma	0.000472	0.00382	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—sarcoma	0.000471	0.00381	CcSEcCtD
Zafirlukast—ABCG2—seminal vesicle—sarcoma	0.00047	0.0196	CbGeAlD
Zafirlukast—Feeling abnormal—Thiotepa—sarcoma	0.00046	0.00372	CcSEcCtD
Zafirlukast—CYP2C8—hematopoietic system—sarcoma	0.000459	0.0191	CbGeAlD
Zafirlukast—Feeling abnormal—Dactinomycin—sarcoma	0.000457	0.00369	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Thiotepa—sarcoma	0.000457	0.00369	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—sarcoma	0.000456	0.00369	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—sarcoma	0.000453	0.00366	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vincristine—sarcoma	0.000451	0.00365	CcSEcCtD
Zafirlukast—Insomnia—Vincristine—sarcoma	0.000448	0.00362	CcSEcCtD
Zafirlukast—Urticaria—Thiotepa—sarcoma	0.000444	0.00359	CcSEcCtD
Zafirlukast—Malaise—Etoposide—sarcoma	0.000443	0.00358	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—sarcoma	0.000443	0.00358	CcSEcCtD
Zafirlukast—Body temperature increased—Thiotepa—sarcoma	0.000442	0.00357	CcSEcCtD
Zafirlukast—Abdominal pain—Thiotepa—sarcoma	0.000442	0.00357	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00044	0.00355	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—sarcoma	0.000438	0.00354	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—sarcoma	0.000438	0.00354	CcSEcCtD
Zafirlukast—CYP1A2—hematopoietic system—sarcoma	0.00043	0.0179	CbGeAlD
Zafirlukast—Gastrointestinal disorder—Vincristine—sarcoma	0.000428	0.00346	CcSEcCtD
Zafirlukast—Fatigue—Vincristine—sarcoma	0.000427	0.00345	CcSEcCtD
Zafirlukast—Dyspepsia—Mitoxantrone—sarcoma	0.000425	0.00343	CcSEcCtD
Zafirlukast—Pain—Vincristine—sarcoma	0.000424	0.00342	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—sarcoma	0.000423	0.00342	CcSEcCtD
Zafirlukast—Fatigue—Mitoxantrone—sarcoma	0.000416	0.00336	CcSEcCtD
Zafirlukast—Discomfort—Etoposide—sarcoma	0.000414	0.00334	CcSEcCtD
Zafirlukast—Pain—Mitoxantrone—sarcoma	0.000413	0.00333	CcSEcCtD
Zafirlukast—Hypersensitivity—Thiotepa—sarcoma	0.000412	0.00333	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—sarcoma	0.000408	0.0033	CcSEcCtD
Zafirlukast—CYP2C9—hematopoietic system—sarcoma	0.000408	0.017	CbGeAlD
Zafirlukast—CYP2E1—seminal vesicle—sarcoma	0.000407	0.0169	CbGeAlD
Zafirlukast—Gastrointestinal pain—Vincristine—sarcoma	0.000405	0.00327	CcSEcCtD
Zafirlukast—Asthenia—Thiotepa—sarcoma	0.000401	0.00324	CcSEcCtD
Zafirlukast—Infection—Etoposide—sarcoma	0.000399	0.00322	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—sarcoma	0.000398	0.00322	CcSEcCtD
Zafirlukast—Feeling abnormal—Mitoxantrone—sarcoma	0.000398	0.00321	CcSEcCtD
Zafirlukast—Pruritus—Thiotepa—sarcoma	0.000395	0.00319	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000394	0.00319	CcSEcCtD
Zafirlukast—Thrombocytopenia—Etoposide—sarcoma	0.000393	0.00318	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—sarcoma	0.000392	0.00317	CcSEcCtD
Zafirlukast—PTGS1—seminal vesicle—sarcoma	0.000392	0.0163	CbGeAlD
Zafirlukast—Body temperature increased—Vincristine—sarcoma	0.000392	0.00317	CcSEcCtD
Zafirlukast—Abdominal pain—Vincristine—sarcoma	0.000392	0.00317	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—sarcoma	0.000391	0.00316	CcSEcCtD
Zafirlukast—CYP2E1—hematopoietic system—sarcoma	0.000386	0.0161	CbGeAlD
Zafirlukast—Urticaria—Mitoxantrone—sarcoma	0.000383	0.0031	CcSEcCtD
Zafirlukast—Diarrhoea—Thiotepa—sarcoma	0.000382	0.00309	CcSEcCtD
Zafirlukast—Abdominal pain—Mitoxantrone—sarcoma	0.000381	0.00308	CcSEcCtD
Zafirlukast—Body temperature increased—Mitoxantrone—sarcoma	0.000381	0.00308	CcSEcCtD
Zafirlukast—Diarrhoea—Dactinomycin—sarcoma	0.000379	0.00307	CcSEcCtD
Zafirlukast—PTGS1—hematopoietic system—sarcoma	0.000372	0.0155	CbGeAlD
Zafirlukast—Neutropenia—Epirubicin—sarcoma	0.00037	0.00299	CcSEcCtD
Zafirlukast—Dizziness—Thiotepa—sarcoma	0.000369	0.00299	CcSEcCtD
Zafirlukast—Hypersensitivity—Vincristine—sarcoma	0.000365	0.00295	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—sarcoma	0.000362	0.00293	CcSEcCtD
Zafirlukast—PTGS1—connective tissue—sarcoma	0.000358	0.0149	CbGeAlD
Zafirlukast—Hypersensitivity—Mitoxantrone—sarcoma	0.000355	0.00287	CcSEcCtD
Zafirlukast—Asthenia—Vincristine—sarcoma	0.000355	0.00287	CcSEcCtD
Zafirlukast—Vomiting—Thiotepa—sarcoma	0.000355	0.00287	CcSEcCtD
Zafirlukast—Vomiting—Dactinomycin—sarcoma	0.000353	0.00285	CcSEcCtD
Zafirlukast—Rash—Thiotepa—sarcoma	0.000352	0.00285	CcSEcCtD
Zafirlukast—Dermatitis—Thiotepa—sarcoma	0.000352	0.00284	CcSEcCtD
Zafirlukast—Headache—Thiotepa—sarcoma	0.00035	0.00283	CcSEcCtD
Zafirlukast—Rash—Dactinomycin—sarcoma	0.00035	0.00283	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Etoposide—sarcoma	0.000346	0.0028	CcSEcCtD
Zafirlukast—Asthenia—Mitoxantrone—sarcoma	0.000346	0.0028	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—sarcoma	0.000346	0.0028	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—sarcoma	0.000346	0.00279	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—sarcoma	0.000344	0.00278	CcSEcCtD
Zafirlukast—Pain—Etoposide—sarcoma	0.000343	0.00277	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—sarcoma	0.000342	0.00277	CcSEcCtD
Zafirlukast—Diarrhoea—Vincristine—sarcoma	0.000339	0.00274	CcSEcCtD
Zafirlukast—ABCG2—uterus—sarcoma	0.000337	0.014	CbGeAlD
Zafirlukast—Nausea—Thiotepa—sarcoma	0.000332	0.00268	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—sarcoma	0.000331	0.00267	CcSEcCtD
Zafirlukast—Feeling abnormal—Etoposide—sarcoma	0.000331	0.00267	CcSEcCtD
Zafirlukast—Diarrhoea—Mitoxantrone—sarcoma	0.00033	0.00267	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—sarcoma	0.000329	0.00266	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—sarcoma	0.000329	0.00266	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Etoposide—sarcoma	0.000328	0.00265	CcSEcCtD
Zafirlukast—PTGS1—smooth muscle tissue—sarcoma	0.000328	0.0137	CbGeAlD
Zafirlukast—Dizziness—Vincristine—sarcoma	0.000328	0.00265	CcSEcCtD
Zafirlukast—PTGS1—skin of body—sarcoma	0.000324	0.0135	CbGeAlD
Zafirlukast—Neuropathy peripheral—Doxorubicin—sarcoma	0.00032	0.00259	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—sarcoma	0.000319	0.00258	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—sarcoma	0.000318	0.00257	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—sarcoma	0.000318	0.00257	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—sarcoma	0.000317	0.00256	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—sarcoma	0.000317	0.00256	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—sarcoma	0.000317	0.00256	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—sarcoma	0.000317	0.00256	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—sarcoma	0.000315	0.00255	CcSEcCtD
Zafirlukast—Vomiting—Vincristine—sarcoma	0.000315	0.00255	CcSEcCtD
Zafirlukast—Rash—Vincristine—sarcoma	0.000312	0.00252	CcSEcCtD
Zafirlukast—Dermatitis—Vincristine—sarcoma	0.000312	0.00252	CcSEcCtD
Zafirlukast—CYP3A4—hematopoietic system—sarcoma	0.000311	0.0129	CbGeAlD
Zafirlukast—Headache—Vincristine—sarcoma	0.00031	0.00251	CcSEcCtD
Zafirlukast—Vomiting—Mitoxantrone—sarcoma	0.000307	0.00248	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—sarcoma	0.000306	0.00247	CcSEcCtD
Zafirlukast—CYP2D6—hematopoietic system—sarcoma	0.000306	0.0127	CbGeAlD
Zafirlukast—Agranulocytosis—Doxorubicin—sarcoma	0.000305	0.00246	CcSEcCtD
Zafirlukast—Rash—Mitoxantrone—sarcoma	0.000304	0.00246	CcSEcCtD
Zafirlukast—Dermatitis—Mitoxantrone—sarcoma	0.000304	0.00246	CcSEcCtD
Zafirlukast—Headache—Mitoxantrone—sarcoma	0.000302	0.00244	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—sarcoma	0.000296	0.00239	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—sarcoma	0.000294	0.00238	CcSEcCtD
Zafirlukast—Nausea—Vincristine—sarcoma	0.000294	0.00238	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—sarcoma	0.000293	0.00237	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—sarcoma	0.000293	0.00237	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—sarcoma	0.000291	0.00236	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—sarcoma	0.000288	0.00233	CcSEcCtD
Zafirlukast—Nausea—Mitoxantrone—sarcoma	0.000287	0.00232	CcSEcCtD
Zafirlukast—ABCG2—bone marrow—sarcoma	0.000286	0.0119	CbGeAlD
Zafirlukast—Pruritus—Etoposide—sarcoma	0.000284	0.00229	CcSEcCtD
Zafirlukast—PTGS1—cardiac atrium—sarcoma	0.000283	0.0118	CbGeAlD
Zafirlukast—PTGS1—uterus—sarcoma	0.000281	0.0117	CbGeAlD
Zafirlukast—Diarrhoea—Etoposide—sarcoma	0.000275	0.00222	CcSEcCtD
Zafirlukast—CYP2C19—liver—sarcoma	0.000272	0.0113	CbGeAlD
Zafirlukast—CYP2E1—lymphoid tissue—sarcoma	0.000272	0.0113	CbGeAlD
Zafirlukast—Back pain—Epirubicin—sarcoma	0.000267	0.00215	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—sarcoma	0.000265	0.00214	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—sarcoma	0.000256	0.00207	CcSEcCtD
Zafirlukast—CYP2E1—tendon—sarcoma	0.000256	0.0107	CbGeAlD
Zafirlukast—Vomiting—Etoposide—sarcoma	0.000255	0.00206	CcSEcCtD
Zafirlukast—Rash—Etoposide—sarcoma	0.000253	0.00205	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—sarcoma	0.000253	0.00204	CcSEcCtD
Zafirlukast—CYP2C8—testis—sarcoma	0.000252	0.0105	CbGeAlD
Zafirlukast—Headache—Etoposide—sarcoma	0.000251	0.00203	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—sarcoma	0.000249	0.00201	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—sarcoma	0.000247	0.00199	CcSEcCtD
Zafirlukast—PTGS1—tendon—sarcoma	0.000246	0.0103	CbGeAlD
Zafirlukast—ABCG2—testis—sarcoma	0.000245	0.0102	CbGeAlD
Zafirlukast—Nausea—Etoposide—sarcoma	0.000238	0.00193	CcSEcCtD
Zafirlukast—CYP2C8—liver—sarcoma	0.000238	0.0099	CbGeAlD
Zafirlukast—Ill-defined disorder—Doxorubicin—sarcoma	0.000237	0.00191	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—sarcoma	0.000235	0.0019	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—sarcoma	0.000235	0.0019	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—sarcoma	0.000232	0.00187	CcSEcCtD
Zafirlukast—ABCG2—liver—sarcoma	0.000231	0.00963	CbGeAlD
Zafirlukast—Malaise—Doxorubicin—sarcoma	0.00023	0.00186	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—sarcoma	0.000225	0.00182	CcSEcCtD
Zafirlukast—Infection—Epirubicin—sarcoma	0.000223	0.00181	CcSEcCtD
Zafirlukast—CYP1A2—liver—sarcoma	0.000223	0.00927	CbGeAlD
Zafirlukast—Thrombocytopenia—Epirubicin—sarcoma	0.00022	0.00178	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—sarcoma	0.000217	0.00175	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—sarcoma	0.000217	0.00175	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—sarcoma	0.000215	0.00173	CcSEcCtD
Zafirlukast—CYP2E1—testis—sarcoma	0.000212	0.00882	CbGeAlD
Zafirlukast—CYP2C9—liver—sarcoma	0.000211	0.0088	CbGeAlD
Zafirlukast—Oedema—Doxorubicin—sarcoma	0.000208	0.00168	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—sarcoma	0.000207	0.00167	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000205	0.00166	CcSEcCtD
Zafirlukast—PTGS1—testis—sarcoma	0.000204	0.0085	CbGeAlD
Zafirlukast—Thrombocytopenia—Doxorubicin—sarcoma	0.000204	0.00165	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—sarcoma	0.000203	0.00164	CcSEcCtD
Zafirlukast—CYP2E1—liver—sarcoma	0.0002	0.00834	CbGeAlD
Zafirlukast—Dyspepsia—Epirubicin—sarcoma	0.000198	0.0016	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—sarcoma	0.000194	0.00157	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—sarcoma	0.000194	0.00157	CcSEcCtD
Zafirlukast—Pain—Epirubicin—sarcoma	0.000192	0.00155	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00019	0.00153	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—sarcoma	0.000188	0.00152	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—sarcoma	0.000185	0.0015	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—sarcoma	0.000184	0.00149	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—sarcoma	0.000183	0.00148	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00018	0.00145	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—sarcoma	0.000179	0.00145	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—sarcoma	0.000179	0.00144	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—sarcoma	0.000178	0.00144	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—sarcoma	0.000178	0.00144	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—sarcoma	0.000178	0.00144	CcSEcCtD
Zafirlukast—ABCG2—lymph node—sarcoma	0.000177	0.00738	CbGeAlD
Zafirlukast—Feeling abnormal—Doxorubicin—sarcoma	0.000172	0.00139	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—sarcoma	0.00017	0.00138	CcSEcCtD
Zafirlukast—CYP2D6—testis—sarcoma	0.000168	0.00698	CbGeAlD
Zafirlukast—Hypersensitivity—Epirubicin—sarcoma	0.000166	0.00134	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—sarcoma	0.000165	0.00134	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—sarcoma	0.000165	0.00133	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—sarcoma	0.000165	0.00133	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—sarcoma	0.000161	0.0013	CcSEcCtD
Zafirlukast—CYP3A4—liver—sarcoma	0.000161	0.00671	CbGeAlD
Zafirlukast—Pruritus—Epirubicin—sarcoma	0.000159	0.00129	CcSEcCtD
Zafirlukast—CYP2D6—liver—sarcoma	0.000158	0.0066	CbGeAlD
Zafirlukast—Diarrhoea—Epirubicin—sarcoma	0.000154	0.00124	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—sarcoma	0.000153	0.00124	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—sarcoma	0.000149	0.00121	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—sarcoma	0.000149	0.0012	CcSEcCtD
Zafirlukast—PTGS1—lymph node—sarcoma	0.000148	0.00616	CbGeAlD
Zafirlukast—Pruritus—Doxorubicin—sarcoma	0.000147	0.00119	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—sarcoma	0.000143	0.00116	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—sarcoma	0.000142	0.00115	CcSEcCtD
Zafirlukast—Rash—Epirubicin—sarcoma	0.000142	0.00115	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—sarcoma	0.000142	0.00115	CcSEcCtD
Zafirlukast—Headache—Epirubicin—sarcoma	0.000141	0.00114	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—sarcoma	0.000138	0.00111	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—sarcoma	0.000134	0.00108	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—sarcoma	0.000132	0.00107	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—sarcoma	0.000131	0.00106	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—sarcoma	0.000131	0.00106	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—sarcoma	0.00013	0.00105	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—sarcoma	0.000124	0.000999	CcSEcCtD
